nprnews_____ = ||| lubuntu at wor2 670N|||The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial||| kickerpage = |||no kicker pagenpr for NPRNEWS||| summarynpr = |||This is the first new drug approved for Alzheimer’s disease since 2003. It’s the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer’s disease.

class=”imagewrap has-source-dimensions”
data-crop-type=”wide”
style=”
–source-width: 4407;
–source-height: 2478;
”
>

The FDA Has Approved A New Alzheimer's Drug — Here's Why That's Controversial

Dr. William Burke goes over a PET brain scan in 2018 at Banner Alzheimers Institute in Phoenix. The drug company Biogen Inc. has received federal approval for a medicine to treat early Alzheimer’s disease.

Matt York/AP


hide caption

toggle caption

Matt York/AP


Health


The FDA Has Approved A New Alzheimer’s Drug — Here’s Why That’s Controversial



This is the first new drug approved for Alzheimer’s disease since 2003. It’s the first to show significant progress against the sticky brain plaques that are the hallmark of Alzheimer’s disease.


Leave a comment

Design a site like this with WordPress.com
Get started